Announcements Trials

Browse Landscape

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Prostatic Neoplasms 1 Patient Satisfaction 1 Neuromuscular Junction Diseases 1 Nervous System Diseases 1 Neoplasms 1 Myasthenia Gravis 1 Muscle Weakness 1 Immune System Diseases 1 COVID-19 1 Autoimmune Diseases of the Nervous System 1 Autoimmune Diseases 1

Interventions

Surveys and Questionnaires 7 COVID-19 Vaccines 4 Surgical Procedures, Operative 3 Specimen Handling 3 Blood Specimen Collection 3 Pandemic Preparedness 2 Data Collection 2 BNT162 Vaccine 2 2019-nCoV Vaccine mRNA-1273 2 sinovac COVID-19 vaccine 1 regorafenib 1 heterologous prime boost COVID-19 vaccination 1 Telemedicine 1 Sorafenib 1 Serologic Tests 1 Patient Reported Outcome Measures 1 Meopa 1 Mastectomy, Segmental 1 High-Throughput Nucleotide Sequencing 1 Drug Therapy 1 Colonoscopy 1 Ad26COVS1 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × COVID-19 × Telemedicine × Clear all

NCT04357574 2026-02-06

CORONA-SHIELD

Duke University

Enrolling by invitation

COVID-19, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡